News

The K+31 West Clinic held a scientific and practical conference that brought together leading experts in the field of oncology, gynecology, radiotherapy, cardiology and other areas. The event discussed modern approaches to the diagnosis and treatment of oncological diseases, as well as issues of interdisciplinary interaction.

On November 6, 2024, the K+31 clinic turns 13! During this time, we have gone from a small medical center to a large network with three branches.

Recently, a young patient with a relapse of metastatic melanoma came to the K+31 West clinic. After successful remission on targeted drugs, the disease made itself felt again. An important task arose - to choose a new approach to treatment...

A CDK4/6 inhibitor in combination with endocrine therapy is the standard first-line therapy for patients with advanced hormone-receptor-positive (HR) breast cancer...

The forum is a significant event in the oncology industry, the oncologist, radiotherapist of the K+31 Clinic - Svetlana Andreevna Ter-Arutyunyants spoke.

Clinic K+31 Petrovsky Gate is resuming its oocyte donation program. For potential donors, this is a great chance not only to make money, but also to give infertile couples a chance at long-awaited parenthood.

Recently, doctors from the K+31 West clinic, Lev Olegovich Kneller and Fadi Salemovich Aude, took part in the Annual Scientific and Practical Conference with International Participation “Vreden Readings”.

Recently, the K+31 West clinic held a special excursion for high school students from the “First Movement” together with RUDN University. Our future doctors saw the international level of medical services, looked into the radiology department, where cancer is treated according to world standards, and learned about advanced diagnostic methods.

Iron administration is associated with a significant reduction in 30-day postoperative mortality and morbidity compared with red blood cell transfusion

Amivantamab plus Lasertinib versus Osimertinib for first-line treatment of EGFR-mutated advanced NSCLC.

Long-term results of adjuvant therapy with dabrafenib and trametinib in stage III melanoma. COMBI-AD study.

The laboratory for the treatment of complex cardiac arrhythmias is open.